No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1667 |
4. Check minimum number of eventsNone |
1667 |
5. Include endpointsNone |
1667 |
6. Filter based on genotype QC (FinnGen only) |
1606 |
Control definitions (FinnGen only)
- Control exclude
- L12_PAPULOSQUAMOUS
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L40
- Name in latin
- Pustulosis palmaris et plantaris
Similar endpoints
↥List of similar endpoints to
Pustulosis palmaris et plantaris
based on the number of shared cases.
Similar with more cases:
- Pustular psoriasis
- Psoriasis
- Papulosquamous disorders
- Autoimmune diseases related-to ILD
- Autoimmune diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 9805 | 6825 | 2953 |
| Only index persons | 9263 | 6578 | 2685 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.16 | 0.20 | 0.08 |
| Only index persons | 0.20 | 0.24 | 0.10 |
| Median age at first event (years) | |||
| Whole population | 51.84 | 53.06 | 49.05 |
| Only index persons | 51.55 | 52.89 | 48.26 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1606 | 1158 | 448 |
| Unadjusted period prevalence (%) | 0.35 | 0.41 | 0.21 |
| Median age at first event (years) | 53.61 | 53.68 | 53.45 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1667
- Matched controls
- 16670
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D05AX52
ATC
calcipotriol, combinations; topical
34.9
307.7
515
211
L40.0
ICD-10 Finland
Psoriasis vulgaris
75.1
307.7
327
54
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
11862.0
307.7
1597
32
D05BB02
ATC
acitretin; oral
119.6
307.7
441
50
D07AD01
ATC
clobetasol; topical
23.9
307.7
1196
1604
D05AX02
ATC
calcipotriol; topical
37.9
307.7
338
111
D07XC01
ATC
betamethasone; topical
9.8
307.7
619
947
D07AC01
ATC
betamethasone; topical
6.4
302.3
1127
4080
E0000UV, ,
ATC
6.5
283.7
1218
4898
L04AX03
ATC
methotrexate; systemic
7.5
264.3
458
804
D05AX03
ATC
calcitriol; topical
84.2
262.1
139
18
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
129.2
259.5
131
11
E000003, ,
ATC
11.2
252.1
290
309
D07AC13
ATC
mometasone; topical
5.2
246.2
926
3235
D07BC01
ATC
betamethasone and antiseptics; topical
6.4
245.3
514
1086
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
316.0
195.6
195
7
TQW80
NOMESCO Finland
Local dermatologic skincare
13.1
175.1
174
147
E000001, ,
ATC
4.3
170.4
613
1970
L40.9
ICD-10 Finland
Psoriasis, unspecified
44.7
163.0
97
23
D02AE01
ATC
carbamide; topical
6.6
160.2
286
504
L40.8
ICD-10 Finland
Other psoriasis
78.4
153.0
82
11
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.9
146.8
601
2087
L40.5
ICD-10 Finland
Arthropathic psoriasis
304.1
138.6
139
5
L04AB04
ATC
adalimumab; parenteral
10.0
106.3
125
134
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
7.9
97.7
140
192
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.9
96.0
328
977
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.8
95.6
240
566
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.3
95.4
281
751
E000002, ,
ATC
4.0
94.9
320
944
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
7.9
94.3
134
182
L30.3
ICD-10 Finland
Infective dermatitis
6.5
86.1
148
247
L04AD01
ATC
ciclosporin; systemic
10.7
85.4
95
94
E000006, ,
ATC
4.3
79.4
224
576
M07.3
ICD-10 Finland
Other psoriatic arthropathies
276.8
78.2
79
*
L01BA01
ATC
methotrexate; systemic
6.1
77.5
140
245
L04AA01
ATC
[U] ciclosporin
11.3
76.1
81
75
A07EC01
ATC
sulfasalazine; oral, rectal
4.0
75.6
237
658
D07CC01
ATC
betamethasone and antibiotics; topical
3.2
70.7
341
1250
N07BA03
ATC
varenicline; oral
4.6
66.1
168
397
L40
ICD-10 Finland
Psoriasis
12.8
65.3
64
52
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
13.5
63.3
60
46
E000004, ,
ATC
7.3
62.7
94
135
J01AA04
ATC
lymecycline; systemic
3.0
61.9
331
1280
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
3.0
61.0
322
1235
J01AA07
ATC
tetracycline; systemic
2.8
61.0
376
1569
L04AA13
ATC
[U] leflunomide
6.7
60.1
98
154
H02AB06
ATC
prednisolone; systemic
2.3
59.5
933
5931
D09AB01
ATC
zinc bandage without supplements; topical
7.8
56.3
79
105
XQ802
NOMESCO Finland
Epicutan test
4.6
55.6
139
323
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.7
54.2
190
566
319
Kela drug reimbursment
Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)
+∞
52.4
50
*
XQ848
NOMESCO Finland
Dermatological photography
5.4
47.4
97
190
68693
ICD-8 Finland
Other local infections of skin and subcutaneous tissue, Pustulosis palmo-plantaris
+∞
47.1
45
*
L04AB01
ATC
etanercept; parenteral
7.8
45.2
63
83
6961D
ICD-9 Finland
Psoriasis and similar disorders, Other psoriasis[PUSTULOSIS PALMOPLANTARIS]
+∞
43.9
42
*
K05.31
ICD-10 Finland
Periodontitis pronounced
2.7
41.3
260
1081
D07AB02
ATC
hydrocortisone butyrate; topical
2.1
40.5
572
3353
D07AB08
ATC
desonide; topical
2.7
39.8
236
950
M13.9
ICD-10 Finland
Arthritis, unspecified
3.1
39.8
185
653
L04AC10
ATC
secukinumab; parenteral
59.1
39.4
46
8
Z72.0
ICD-10 Finland
Tobacco use
5.0
38.7
86
181
E000007, ,
ATC
3.5
38.2
137
412
D02AX
ATC
Other emollients and protectives
4.9
38.1
87
187
L88
ICPC
Rheumatoid/seropositive arthritis
4.0
37.3
112
298
J01FF01
ATC
clindamycin; systemic
2.0
34.9
522
3093
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.1
34.1
438
2454
S29
ICPC
Skin symptom/complaint other
2.2
33.9
363
1897
S91
ICPC
Psoriasis
39.1
33.5
42
11
J01DB01
ATC
cefalexin; oral
2.3
32.8
1426
11960
L04AB06
ATC
golimumab; parenteral
9.5
32.8
39
42
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.0
31.7
433
2471
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.8
31.6
175
677
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
5.3
31.6
64
124
L43.0
ICD-10 Finland
Hypertrophic lichen planus
71.3
31.0
35
5
103
Kela drug reimbursment
Diabetes, insulin-treated
2.0
30.7
449
2620
A10BA02
ATC
metformin; oral
1.9
30.6
482
2884
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.5
30.1
214
936
D07AC14
ATC
methylprednisolone aceponate; topical
3.3
30.1
118
375
S21
ICPC
Skin texture symptom/complaint
2.2
29.8
275
1348
T90
ICPC
Diabetes non-insulin dependent
2.0
29.8
415
2378
EBA00
NOMESCO Finland
Extraction of tooth
1.8
28.6
624
4126
N02AX02
ATC
tramadol; systemic, rectal
1.8
28.1
751
5263
B35.3
ICD-10 Finland
Tinea pedis
3.4
27.2
99
300
L43.8
ICD-10 Finland
Other lichen planus
10.5
27.2
30
29
L30.0
ICD-10 Finland
Nummular dermatitis
3.7
27.0
88
248
L08.0
ICD-10 Finland
Pyoderma
9.1
26.9
33
37
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.4
26.3
189
829
P17
ICPC
Tobacco abuse
5.9
26.3
47
81
377
Kela drug reimbursment
Apremilast and dimethyl fumarate (psoriasis)
+∞
26.1
25
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
25.4
743
5297
L04AC13
ATC
ixekizumab; parenteral
71.0
24.9
28
*
J01DA01
ATC
[U] cefalexin
1.7
24.7
1070
8464
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.8
24.3
124
459
S99
ICPC
Skin disease other
4.6
24.2
58
130
L04AX01
ATC
azathioprine; systemic
3.3
23.8
94
300
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
6.6
23.5
38
59
WZA10
NOMESCO Finland
Extensive medical or dental certificate
5.8
23.4
43
76
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.9
23.4
381
2277
L04AA32
ATC
apremilast; oral
+∞
23.0
22
*
L40.1
ICD-10 Finland
Generalized pustular psoriasis
233.1
22.7
23
*
P01AB01
ATC
metronidazole; oral, rectal
1.7
22.4
736
5357
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.2
22.3
90
291
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.8
21.9
416
2599
D11AH04
ATC
alitretinoin; oral
39.2
21.7
27
7
D01BA02
ATC
terbinafine; oral
1.8
21.1
433
2763
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
20.7
371
2273
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.0
20.6
266
1466
SPAT1263
SPAT
Sampling
1.6
20.6
677
4896
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.4
20.4
156
701
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
19.7
761
5707
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
19.7
693
5081
L43.9
ICD-10 Finland
Lichen planus, unspecified
6.9
19.6
30
44
L04AC05
ATC
ustekinumab; parenteral
26.4
19.1
26
10
D05AA
ATC
Tars
18.4
19.1
29
16
SPAT1262
SPAT
Handing over of treatment supplies
1.9
18.8
277
1592
A10BH01
ATC
sitagliptin; oral
2.2
18.8
164
779
M07.0*L40.5
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
+∞
18.8
18
*
M073, L403,
ICD-10 Finland
+∞
18.8
18
*
R03AC02
ATC
salbutamol; inhalant
1.6
18.7
935
7422
M13.1
ICD-10 Finland
Monoarthritis, not elsewhere classified
6.0
18.3
32
54
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
18.1
325
1984
A46
ICD-10 Finland
Erysipelas
2.0
17.9
226
1234
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.2
17.8
169
830
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.2
17.8
167
817
L04AC16
ATC
guselkumab; systemic
181.9
17.5
18
*
R06AE07
ATC
cetirizine; oral
1.6
17.4
757
5783
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.2
17.3
70
227
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.4
17.3
121
523
R95
ICPC
Chron obstructive pulmonary disease
3.5
17.2
59
172
D07AC03
ATC
desoximetasone; topical
4.4
17.2
43
100
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
4.6
16.9
40
89
L17
ICPC
Foot/toe symptom/complaint
1.6
16.7
480
3319
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
16.5
594
4334
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
3.4
16.1
59
180
M54.5
ICD-10 Finland
Low back pain
1.6
16.1
606
4461
SPAT1283
SPAT
Restricted health certificate
1.8
15.8
270
1621
L40.4
ICD-10 Finland
Guttate psoriasis
60.6
15.8
18
*
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
15.7
623
4631
R02
ICPC
Shortness of breath/dyspnoea
1.9
15.7
212
1181
K50.0
ICD-10 Finland
Crohn disease of small intestine
4.5
15.7
38
86
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.7
15.7
83
313
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.9
15.4
214
1204
M25.5
ICD-10 Finland
Pain in joint
1.6
15.4
565
4126
A02BC02
ATC
pantoprazole; systemic
1.6
15.2
1125
9534
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
3.1
15.2
63
207
L30.4
ICD-10 Finland
Erythema intertrigo
4.5
15.2
37
84
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
15.2
488
3453
H02AB07
ATC
prednisone; oral
1.8
15.2
234
1360
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
15.1
202
1121
134
Kela drug reimbursment
General erythroderma
45.4
15.1
18
*
ZY010
NOMESCO Finland
Hospital outpatient
2.5
15.1
94
385
SPAT1301
SPAT
No procedures
1.6
15.0
469
3296
D01AE15
ATC
terbinafine; topical
2.3
14.9
119
544
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.8
14.8
76
282
L30.8
ICD-10 Finland
Other specified dermatitis
3.2
14.7
58
185
A10BK03
ATC
empagliflozin; oral
2.0
14.7
168
884
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.3
14.3
116
535
R03BB04
ATC
tiotropium bromide; inhalant
2.0
14.2
162
852
L20.0
ICD-10 Finland
Besnier prurigo
2.2
14.0
123
585
S97
ICPC
Chronic ulcer skin
2.4
14.0
97
417
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.0
13.9
159
837
P01BA02
ATC
hydroxychloroquine; oral
2.0
13.8
154
802
S10
ICPC
Boil/carbuncle
2.3
13.6
105
474
L73.2
ICD-10 Finland
Hidradenitis suppurativa
4.5
13.6
33
75
L40.2
ICD-10 Finland
Acrodermatitis continua
+∞
13.6
13
*
M07.2*L40.5
ICD-10 Finland
Psoriatic spondylitis
+∞
13.6
13
*
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.6
13.5
360
2429
S76
ICPC
Skin infection other
2.4
13.4
93
401
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.2
13.3
108
498
L30.1
ICD-10 Finland
Dyshidrosis [pompholyx]
9.8
13.2
26
27
M03BX02
ATC
tizanidine; oral
1.5
13.2
1060
8995
L20
ICPC
Joint symptom/complaint NOS
2.7
13.2
70
265
SPAT1312
SPAT
General health counselling
1.5
13.1
477
3451
M79.6
ICD-10 Finland
Pain in limb
1.5
13.1
686
5351
NH3EA
NOMESCO Finland
Feet X-ray examination with load
3.5
13.1
44
127
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
13.0
1173
10175
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.1
12.9
118
571
D05AX05
ATC
tazarotene; topical
50.4
12.8
15
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.8
12.7
62
224
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.1
12.7
120
588
M10.9
ICD-10 Finland
Gout, unspecified
2.3
12.5
94
419
L04AC18
ATC
risankizumab; parenteral
+∞
12.5
12
*
M07.0
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
+∞
12.5
12
*
A10BJ06
ATC
semaglutide; parenteral
2.3
12.4
95
428
L03
ICPC
Low back symptom/complaint
1.5
12.3
449
3245
D07AA02
ATC
hydrocortisone; topical
1.8
12.2
215
1298
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
12.1
680
5351
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.9
12.1
151
818
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
12.0
1149
9993
S87
ICPC
Dermatitis/atopic eczema
3.2
12.0
47
150
A10AE04
ATC
insulin glargine; parenteral
2.0
12.0
140
742
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.3
11.9
91
409
SPAT1260
SPAT
Consultation of another employee
1.6
11.7
268
1735
N05AH02
ATC
clozapine; systemic
3.6
11.6
38
108
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
11.6
892
7424
L04AA11
ATC
[U] etanercept
11.2
11.5
21
19
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.6
11.5
66
260
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.1
11.5
116
583
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
2.9
11.5
53
186
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
11.5
450
3292
N05CD07
ATC
temazepam; oral
1.8
11.5
177
1026
S18
ICPC
Laceration/cut
1.4
11.5
695
5532
6961A
ICD-9 Finland
Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]
+∞
11.5
11
*
XQ800
NOMESCO Finland
Prick test
2.0
11.5
132
696
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
3.1
11.3
46
150
N02BE01
ATC
paracetamol; systemic, rectal
1.7
11.3
1461
13455
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
11.2
199
1204
WZA90
NOMESCO Finland
Other medical or dental certificate
1.5
11.1
366
2580
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.8
11.0
180
1061
L43.3
ICD-10 Finland
Subacute (active) lichen planus
43.6
10.9
13
*
SDA12
NOMESCO Finland
Treatment of complicated periodontal disease
3.2
10.9
42
133
D01AC02
ATC
miconazole; topical
2.0
10.8
119
617
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.8
10.8
185
1106
N03AX16
ATC
[U] pregabalin
1.5
10.8
378
2698
L08
ICPC
Shoulder symptom/complaint
1.5
10.8
351
2466
SPAT1310
SPAT
Counselling related to known health issue
1.5
10.7
472
3526
J01DA09
ATC
[U] cefadroxil
1.5
10.7
427
3127
N05AH04
ATC
quetiapine; oral
1.6
10.7
273
1812
SDA04
NOMESCO Finland
Demanding periodontal treatment
1.5
10.7
443
3270
R4180
NOMESCO Finland
Podiatric therapy
4.2
10.6
28
68
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
3.5
10.6
36
105
N05BA04
ATC
oxazepam; oral
1.5
10.5
408
2970
K02.1
ICD-10 Finland
Caries of dentine
1.4
10.5
925
7824
R06AE09
ATC
levocetirizine; oral
1.6
10.5
241
1559
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
3.2
10.5
41
131
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.4
10.4
73
316
A07EA06
ATC
budesonide; oral, local oral
2.5
10.3
64
262
K50.8
ICD-10 Finland
Other Crohn disease
3.6
10.2
33
93
A10AB05
ATC
insulin aspart; parenteral
2.0
10.2
107
546
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
10.2
536
4137
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
10.1
822
6838
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.7
10.1
201
1251
N05CF01
ATC
zopiclone; oral
1.4
10.1
499
3806
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
3.8
10.1
30
80
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
10.0
1055
9167
N06AX21
ATC
duloxetine; oral
1.7
10.0
204
1280
C10AA01
ATC
simvastatin; oral
1.4
9.9
573
4490
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.8
9.9
169
1008
Z3231
NOMESCO Finland
Registered nurse
1.5
9.9
403
2957
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
2.7
9.9
52
196
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.5
9.9
409
3012
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
9.9
299
2063
J01FA06
ATC
roxithromycin; oral
1.4
9.9
643
5146
S01
ICPC
Pain/tenderness of skin
2.3
9.8
74
331
L85.1
ICD-10 Finland
Acquired keratosis [keratoderma] palmaris et plantaris
26.2
9.8
13
5
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
4.6
9.8
23
51
N06AX11
ATC
mirtazapine; oral
1.4
9.8
534
4142
F17.2
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, dependence syndrome
4.7
9.8
22
47
A02BC01
ATC
omeprazole; systemic
1.5
9.8
405
2983
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.5
9.8
424
3151
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
9.7
379
2757
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.1
9.7
40
132
L28
ICPC
Limited function/disability (L)
1.6
9.7
246
1631
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.5
9.6
57
229
N06AB04
ATC
citalopram; systemic
1.5
9.6
334
2375
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
3.1
9.5
39
128
N05BA01
ATC
diazepam; systemic, rectal
1.6
9.5
210
1343
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
3.1
9.5
38
123
N06AA09
ATC
amitriptyline; systemic
1.7
9.5
164
982
K05.3
ICD-10 Finland
Chronic periodontitis
2.1
9.5
85
409
A01
ICPC
Pain general/multiple sites
1.8
9.4
145
840
69619
ICD-8 Finland
Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)
+∞
9.4
9
*
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
9.3
425
3183
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
2.5
9.3
57
232
L04AB05
ATC
certolizumab pegol; parenteral
8.7
9.3
19
22
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.0
9.3
94
474
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.8
9.2
142
822
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
9.2
195
1235
M01AB05
ATC
diclofenac; systemic, rectal
1.4
9.2
1074
9428
K50.1
ICD-10 Finland
Crohn disease of large intestine
3.9
9.1
26
67
SFA10
NOMESCO Finland
One-surface restoration
1.4
9.1
860
7284
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
9.1
291
2028
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
4.3
9.1
23
54
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.7
9.1
188
1182
D06AX01
ATC
fusidic acid; topical
1.8
9.1
144
841
N05AX08
ATC
risperidone; systemic
1.9
9.1
113
612
EBA30
NOMESCO Finland
Extraction of root of tooth
2.0
9.0
91
458
8511
FHL
Cervical dilation and drainage with suction
2.2
9.0
76
357
R05
ICPC
Cough
1.5
9.0
368
2698
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
8.9
546
4305
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.2
8.9
77
366
N05BB01
ATC
hydroxyzine; systemic
2.0
8.9
100
524
M01AH01
ATC
celecoxib; oral
1.5
8.8
285
1990
M01CB03
ATC
auranofin; oral
4.9
8.8
19
39
SPAT1254
SPAT
Administration of medicine
1.6
8.8
189
1202
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
8.7
167
1029
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
8.7
169
1046
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
3.6
8.7
28
79
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
50.3
8.7
10
*
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
3.2
8.7
34
109
SFA30
NOMESCO Finland
Three-surface restoration
1.4
8.7
680
5579
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
8.6
429
3259
J01AA02
ATC
doxycycline; systemic
1.4
8.6
1270
11521
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.7
8.6
45
170
G47.3
ICD-10 Finland
Sleep apnoea
1.5
8.6
338
2458
SDA03
NOMESCO Finland
Periodontal treatment
1.4
8.6
633
5142
N03AX09
ATC
lamotrigine; oral
2.1
8.5
79
385
C03CA01
ATC
furosemide; systemic
1.5
8.4
360
2658
WQ031, ,
NOMESCO Finland
90.5
8.4
9
*
M45
ICD-10 Finland
Ankylosing spondylitis
2.9
8.4
39
138
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
8.4
744
6212
L23.8
ICD-10 Finland
Allergic contact dermatitis due to other agents
6.7
8.4
20
30
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.2
8.4
68
315
H02AB04
ATC
methylprednisolone; systemic
1.6
8.3
225
1510
WX290
NOMESCO Finland
Other blockage of nerve
1.4
8.3
723
6017
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.9
8.3
101
544
K05.30
ICD-10 Finland
Periodontitis complex
1.6
8.3
222
1488
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
8.3
147
888
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.3
8.2
59
259
S02
ICPC
Pruritus
2.4
8.2
55
234
H29
ICPC
Ear symptom/complaint other
1.7
8.2
165
1030
J01CF05
ATC
flucloxacillin; systemic
2.0
8.2
93
489
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.9
8.1
36
124
J01MA12
ATC
levofloxacin; systemic
1.5
8.1
261
1819
K04.7
ICD-10 Finland
Periapical abscess without sinus
2.0
8.1
93
490
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.8
8.0
113
637
-1, ,
NOMESCO Finland
1.4
8.0
492
3867
N03AX12
ATC
[U] gabapentin; oral
1.5
8.0
257
1790
R52.9
ICD-10 Finland
Pain, unspecified
1.7
8.0
150
919
D07CB01
ATC
triamcinolone and antibiotics; topical
2.9
8.0
37
131
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.1
8.0
72
348
K50.9
ICD-10 Finland
Crohn disease, unspecified
3.2
8.0
31
99
C07AB07
ATC
bisoprolol; oral
1.3
8.0
687
5698
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
8.0
734
6149
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.7
7.9
151
929
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
7.9
595
4829
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.9
7.9
92
488
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
7.9
144
876
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
4.0
7.9
22
56
H01
ICPC
Ear pain/earache
1.6
7.8
170
1083
A10BK01
ATC
dapagliflozin; oral
1.9
7.8
102
562
Z2446
NOMESCO Finland
Social worker
1.9
7.8
98
533
N06AG02
ATC
moclobemide; oral
2.1
7.8
73
358
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.5
7.8
48
197
R21
ICPC
Throat symptom/complaint
1.5
7.7
296
2139
A10BJ02
ATC
liraglutide; parenteral
2.4
7.7
53
229
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
4.0
7.6
21
53
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.7
7.6
136
823
S22
ICPC
Nail symptom/complaint
1.9
7.6
98
539
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
7.5
553
4465
L12
ICPC
Hand/finger symptom/complaint
1.5
7.5
240
1669
EBA00, ,
SPAT
2.4
7.5
49
207
S22.3
ICD-10 Finland
Fracture of rib
1.8
7.5
106
600
N05AX12
ATC
aripiprazole; systemic
2.2
7.4
59
271
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
7.4
188
1244
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
7.4
153
963
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
7.4
266
1897
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
6.0
7.4
19
32
D82
ICPC
Teeth/gum disease
1.4
7.4
557
4516
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.4
7.3
318
2349
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
4.2
7.3
19
46
TNG10
NOMESCO Finland
Puncture of knee
3.5
7.3
24
69
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.7
7.3
130
787
NG1DA
NOMESCO Finland
X-ray of knees
2.9
7.2
33
116
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
2.6
7.2
39
150
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
7.2
582
4762
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.8
7.2
106
608
L23.9
ICD-10 Finland
Allergic contact dermatitis, unspecified cause
3.6
7.2
23
65
WQ021, ,
NOMESCO Finland
20.1
7.1
10
5
D07XB01
ATC
flumetasone; topical
6.6
7.1
17
26
L14
ICPC
Leg/thigh symptom/complaint
1.7
7.1
119
708
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.6
7.1
189
1265
R50.9
ICD-10 Finland
Fever, unspecified
1.5
7.0
206
1410
SPAT1153
SPAT
Removal of sutures
1.4
7.0
453
3583
F03
ICPC
Eye discharge
1.8
6.9
103
592
J01MA02
ATC
ciprofloxacin; systemic
1.3
6.9
548
4467
SPAT1104
SPAT
Monitoring of emergency patient
1.9
6.9
87
475
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.8
6.9
108
631
M01AH05
ATC
etoricoxib; oral
1.3
6.9
1006
8931
R60.0
ICD-10 Finland
Localized oedema
1.6
6.8
165
1078
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
3.3
6.8
25
77
A07EC02
ATC
mesalazine; oral, rectal
1.9
6.8
80
426
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.4
6.8
45
191
Z01.2
ICD-10 Finland
Dental examination
1.3
6.8
692
5841
OAA67, ,
SPAT
0.6
6.8
90
1544
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
6.8
433
3413
L16
ICPC
Ankle symptom/complaint
1.6
6.8
169
1114
N05AA02
ATC
levomepromazine; systemic
2.1
6.7
64
316
N05AB03
ATC
perphenazine; systemic, rectal
2.1
6.7
58
276
N05AF03
ATC
chlorprothixene; systemic
2.4
6.7
43
180
M04AA01
ATC
allopurinol; systemic
1.6
6.7
147
939
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
2.3
6.7
49
218
WQ020, ,
NOMESCO Finland
22.6
6.7
9
*
L99
ICPC
Musculoskeletal disease other
2.7
6.7
35
133
N02AA05
ATC
oxycodone; systemic
1.5
6.7
229
1617
L04
ICPC
Chest symptom/complaint
1.8
6.7
97
554
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
6.6
254
1832
A02BC03
ATC
lansoprazole; oral
1.4
6.6
438
3470
L02
ICPC
Back symptom/complaint
1.6
6.6
147
943
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
3.2
6.6
25
79
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
3.3
6.6
24
74
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
6.5
1475
13940
6350C
ICD-9 Finland
Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]
1.9
6.5
85
469
N05AH03
ATC
olanzapine; systemic
1.8
6.5
95
543
UJF92
NOMESCO Finland
Capsular endoscopy
2.7
6.5
34
129
J04BA02
ATC
dapsone; oral
6.2
6.5
16
26
SPAT1211
SPAT
Application of soft bandage
1.7
6.5
118
719
N06AX16
ATC
venlafaxine; oral
1.5
6.5
228
1618
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.6
6.4
145
932
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
6.4
138
879
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
3.8
6.4
19
51
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
2.4
6.3
43
185
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.8
6.3
91
518
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.0
6.3
69
359
SPAT1202
SPAT
Intra-articular injection
2.3
6.3
45
198
J45.1
ICD-10 Finland
Nonallergic asthma
1.7
6.3
104
616
S06
ICPC
Rash localized
1.9
6.3
79
431
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
2.8
6.3
29
103
S17
ICPC
Abrasion/scratch/blister
2.7
6.3
32
120
A02BC05
ATC
esomeprazole; systemic
1.3
6.3
628
5273
299, ,
Kela drug reimbursment
+∞
6.3
6
*
L04AC21
ATC
bimekizumab; systemic
+∞
6.3
6
*
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
3.0
6.2
26
87
SPD00
NOMESCO Finland
Mucosa borne complete denture
3.7
6.2
19
52
Z3229
NOMESCO Finland
Other healthcare associate professional
1.7
6.2
113
689
J02AC02
ATC
itraconazole; systemic
1.4
6.2
275
2038
SDA05
NOMESCO Finland
Very demanding periodontal treatment
1.8
6.2
97
567
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
6.1
860
7539
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
6.1
217
1542
M66.0
ICD-10 Finland
Rupture of popliteal cyst
3.0
6.1
25
83
UJF32
NOMESCO Finland
Coloscopy
1.4
6.1
369
2879
R06.0
ICD-10 Finland
Dyspnoea
1.4
6.0
368
2873
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
2.7
6.0
30
111
L04AK01
ATC
leflunomide; oral
5.2
6.0
17
33
SPAT1229
SPAT
Assessment of need for aid
1.7
6.0
96
564
SPF02
NOMESCO Finland
Impression for dental prosthesis repair, restricted
3.3
6.0
22
68
D11
ICPC
Diarrhoea
1.5
6.0
163
1095
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1129
7030
2.88
88.19
9.5
5.6
2.16
1.97
e9/l
3.55
1034
6254
1136
7097
2.89
88.16
9.8
5.8
0.21
0.19
e9/l
8.06
1039
6245
1044
6408
2.68
80.97
9.6
5.6
2.92
2.84
%
0.72
994
5985
1053
6547
2.65
78.57
9.3
5.5
57.13
56.54
%
0.91
999
6136
1059
6639
2.63
77.06
9.6
5.7
28.47
28.68
%
0.29
1009
6232
1190
8057
2.67
71.11
12.8
9.0
4.41
3.95
e9/l
12.50
1073
7074
149
378
4.23
53.23
1.6
1.5
0.00
0.07
iu/ml
1.37
25
72
42
28
15.36
47.78
1.5
1.3
9.60
8.72
ug/l
0.44
42
28
247
1030
2.64
38.83
4.1
4.0
0.40
0.76
%
2.53
78
332
1330
10841
2.12
33.12
9.8
7.4
79.19
77.27
u/l
0.73
1259
10240
1291
10499
2.02
31.02
6.9
3.9
15.56
11.85
mm/h
13.51
1209
9754
613
4099
1.78
26.58
3.5
3.1
7.21
7.31
mmol/l
0.21
499
3509
107
352
3.18
25.76
1.6
1.3
—
—
—
0
0
576
3858
1.75
24.35
3.5
3.2
508.50
362.13
mg/l
0.27
358
2370
598
4062
1.74
23.96
4.2
3.7
8.52
8.40
mg/mmol
0.02
363
2479
84
262
3.32
22.06
3.9
3.6
55.65
57.60
%
0.72
84
262
883
6765
1.65
21.75
4.2
3.5
0.00
0.00
estimate
0.75
197
1317
886
6794
1.65
21.75
5.7
4.7
0.00
0.00
estimate
0.50
190
1245
893
6863
1.65
21.71
4.4
3.5
0.00
0.01
estimate
1.32
181
1212
52
117
4.56
21.58
1.7
1.4
25.53
34.32
%
0.74
31
72
404
2519
1.80
21.39
1.4
1.3
14.14
11.91
u/ml
0.25
146
1021
777
5783
1.64
21.32
4.8
4.7
35.24
35.89
g/l
2.71
716
5412
29
38
7.75
20.85
1.7
2.1
6.58
9.42
mg/l
1.94
24
31
867
6691
1.62
20.11
6.4
6.6
1.22
1.22
mmol/l
0.40
737
5712
90
315
2.96
19.48
2.0
1.7
13015.01
10876.99
e6/l
0.27
68
234
781
5920
1.60
19.20
2.6
2.2
74.59
77.71
nmol/l
2.51
715
5358
58
156
3.82
19.04
1.7
1.5
55.86
60.47
%
0.32
36
101
512
3516
1.66
18.71
3.0
2.5
1076.23
4798.12
umol/l
3.55
438
3105
407
2646
1.71
18.22
1.4
1.3
30.74
33.37
iu/ml
0.15
117
891
786
6074
1.56
17.07
5.7
5.9
1.22
1.22
mmol/l
0.61
724
5549
547
3910
1.59
16.59
1.9
1.7
1.65
1.40
mmol/l
6.01
448
3318
544
3917
1.58
15.83
3.3
3.0
33.54
105.86
e6/l
1.93
428
2974
502
3578
1.58
15.14
3.3
2.9
0.55
0.45
e6/l
0.25
393
2686
553
4054
1.54
14.62
2.3
2.1
196.37
214.23
u/l
0.19
506
3823
1527
14066
2.02
14.37
19.4
12.9
20.58
21.94
mg/l
1.02
1327
10990
890
7234
1.49
14.23
5.8
6.3
9.34
10.86
umol/l
5.57
838
6873
395
2702
1.61
14.02
2.6
2.5
6.48
6.69
e6/l
0.09
359
2419
690
5377
1.48
13.30
2.1
1.9
94.08
97.11
pmol/l
0.99
380
2713
752
5969
1.47
13.16
10.9
12.8
1.14
1.20
inr
1.47
251
1755
57
196
2.98
12.79
1.7
3.4
1.67
1.55
%
0.08
50
179
492
3617
1.51
12.43
4.7
3.9
0.00
0.01
estimate
1.28
185
1220
269
1720
1.67
12.36
3.2
2.2
180.19
122.44
ug/g
1.13
217
1361
942
7865
1.45
12.36
5.0
4.6
6.86
6.63
mmol/l
2.46
898
7375
571
4341
1.48
12.19
3.0
2.5
52.25
59.47
u/l
3.09
515
4022
1051
8984
1.46
12.01
4.8
4.2
178.54
2478.51
e6/l
2.52
13
132
441
3193
1.52
11.90
1.3
1.2
2.00
1.41
u/ml
0.21
104
880
389
2757
1.54
11.54
1.4
1.4
2.87
2.35
g/l
4.64
217
1714
26
57
4.62
11.20
1.2
1.1
391.70
241.95
iu/ml
0.30
26
57
296
1992
1.59
10.99
1.9
1.8
—
—
—
0
0
316
2160
1.57
10.97
3.6
3.5
0.79
0.82
mmol/l
5.07
291
2038
162
931
1.82
10.81
1.4
1.7
—
—
—
0
0
319
2195
1.56
10.74
2.9
2.5
1.27
1.09
e6/l
0.45
178
1216
176
1047
1.76
10.45
2.1
2.7
10.99
10.36
g/l
1.13
158
957
1416
13023
1.58
9.98
7.0
5.4
41.44
39.39
mmol/mol
11.64
1309
12141
252
1677
1.59
9.74
4.4
5.7
1.03
1.03
mmol/l
0.03
233
1549
320
2250
1.52
9.68
1.8
1.7
1008.07
1204.95
nmol/l
4.31
246
1711
172
1057
1.70
9.08
2.3
2.9
67.34
66.89
g/l
0.34
162
967
426
3212
1.44
8.99
2.3
2.1
3.08
2.98
mg/l
0.32
360
2737
646
5246
1.38
8.82
4.6
3.6
—
—
—
0
0
88
444
2.04
8.68
1.7
1.8
—
—
—
0
0
289
2040
1.50
8.50
3.1
2.7
5.39
2.79
e6/l
1.28
148
1070
38
132
2.92
8.46
1.5
1.3
43159.63
140248.90
e6/l
0.65
24
93
1418
13163
1.52
8.32
5.7
4.9
1.77
2.12
mu/l
1.44
1316
12143
1582
15098
1.94
8.27
16.7
10.0
26.22
25.73
u/l
0.60
1546
14621
196
1277
1.61
8.23
2.3
2.1
367.89
371.86
nmol/l
0.11
178
1178
104
568
1.89
8.17
1.3
1.2
0.22
1.08
u/ml
—
10
45
282
2005
1.49
7.98
2.2
2.4
12.27
13.58
umol/l
2.46
265
1861
1233
11193
1.39
7.80
4.8
4.2
14.85
14.72
pmol/l
1.00
1136
10269
1444
13502
1.52
7.69
17.7
11.9
84.81
82.28
ml/min/173m2
4.62
1226
11153
150
938
1.66
7.42
3.8
3.4
4.55
4.51
pmol/l
0.19
138
833
575
4683
1.35
7.37
3.7
3.2
33.77
31.65
u/l
0.32
532
4469
19
33
5.81
7.22
1.8
2.8
—
35.00
—
0
7
1470
13838
1.53
7.14
5.2
4.4
6.22
5.87
mmol/l
16.00
1337
12707
10
5
20.11
7.13
1.8
2.8
2.00
3.38
mg/l
—
10
5
1327
12265
1.40
7.01
23.6
15.5
15.11
14.88
%
0.75
1310
12036
1528
14534
1.62
6.81
18.9
14.5
139.62
139.77
mmol/l
1.53
1491
14183
1499
14204
1.55
6.69
5.6
4.4
4.67
4.81
mmol/l
6.47
1402
13259
1062
9539
1.31
6.44
3.8
3.0
53.81
46.12
u/l
1.25
978
8930
199
1376
1.51
6.40
2.9
4.8
247.63
246.44
u/l
0.02
190
1306
70
365
1.96
6.37
2.1
1.7
—
—
—
0
0
81
445
1.86
6.31
1.8
1.7
—
—
—
0
0
330
2515
1.39
6.30
1.4
1.5
—
—
—
0
0
73
388
1.92
6.29
3.0
2.7
—
—
—
0
0
361
2797
1.37
6.23
1.8
1.6
62500418.09
33861059.71
pmol/l
0.24
296
2339
76
411
1.89
6.22
1.6
1.7
0.25
0.24
g/l
0.34
71
392
1488
14115
1.50
6.20
5.0
4.3
1.43
1.52
mmol/l
14.30
1375
13112
89
507
1.80
6.18
1.9
2.4
—
—
—
0
0
69
362
1.95
6.18
1.3
1.3
—
—
—
0
0
1514
14417
1.55
6.16
5.7
4.8
2.76
2.86
mmol/l
3.94
1404
13390
437
3495
1.34
6.12
2.8
2.9
1513.86
1024.43
ng/l
1.27
355
2951
381
2985
1.36
6.11
1.5
1.5
19.85
21.35
nmol/l
1.06
321
2554
1527
14577
1.57
6.04
19.0
14.7
3.98
3.95
mmol/l
3.16
1491
14203
61
309
2.01
6.04
2.0
2.3
77.44
97.45
ug/min
0.21
30
192
199
1396
1.48
5.97
1.8
1.7
—
—
—
0
0
432
3465
1.33
5.91
3.8
3.7
94.77
93.96
%
0.28
412
3366
82
463
1.81
5.87
2.0
2.4
10.35
10.14
g/l
0.16
76
424
248
1821
1.43
5.85
2.1
2.4
2.46
2.37
g/l
1.84
230
1682
47
218
2.19
5.85
1.2
1.1
12466.04
116.35
iu/ml
—
10
48
156
1048
1.54
5.75
3.5
3.5
72.79
80.30
ng/l
0.91
134
915
159
1075
1.53
5.69
3.5
3.5
2.14
1.95
mmol/l
0.22
137
901
50
241
2.11
5.66
1.3
1.2
—
—
—
0
0
199
1412
1.46
5.63
1.8
1.7
—
—
—
0
0
232
1696
1.43
5.60
2.1
2.5
19.43
23.19
%
4.43
198
1444
567
4752
1.29
5.58
3.0
3.4
2.36
2.36
mmol/l
0.75
501
4244
594
5011
1.29
5.55
3.8
3.3
41.39
40.39
ng/l
0.03
378
3231
182
1277
1.48
5.45
2.0
2.2
0.23
0.22
g/l
1.17
167
1208
188
1334
1.46
5.32
2.1
2.8
1.77
1.84
%
0.62
168
1195
157
1080
1.50
5.19
3.5
3.5
5.99
5.84
kpa
0.82
151
1047
223
1641
1.41
5.19
1.8
1.8
1.73
1.42
%
5.14
185
1452
196
1413
1.44
5.11
6.5
8.2
1.36
1.19
mmol/l
0.20
165
1134
187
1342
1.44
4.99
3.7
3.1
—
—
—
0
0
72
413
1.78
4.94
2.6
2.2
545.20
380.12
ug/l
0.24
67
386
195
1414
1.43
4.92
6.5
8.2
5.33
5.11
kpa
2.40
188
1360
195
1414
1.43
4.92
6.5
8.2
11.54
12.65
kpa
2.49
187
1360
70
399
1.79
4.91
1.7
1.4
241.59
298.40
ug/g
1.45
39
223
1435
13630
1.38
4.88
4.9
3.9
1.53
1.30
mmol/l
16.87
1321
12579
43
209
2.09
4.81
5.9
5.6
390.56
375.51
umol/l
0.26
34
187
364
2932
1.31
4.71
4.8
3.8
1.02
1.02
kg/l
0.01
52
415
82
496
1.69
4.68
1.9
1.9
—
—
—
0
0
156
1095
1.47
4.68
3.7
3.8
1.23
1.23
mmol/l
0.34
136
952
48
246
1.98
4.67
4.1
2.4
16.53
16.37
%
0.12
26
128
88
1372
0.62
4.57
1.8
1.7
—
—
—
0
0
66
381
1.76
4.46
2.9
3.7
2.07
1.75
ratio
—
10
37
386
3164
1.29
4.35
1.7
1.8
1.10
1.09
mg/l
0.01
303
2395
314
2508
1.31
4.30
4.1
3.4
255.29
311.15
ng/l
0.18
222
1823
20
72
2.80
4.29
1.5
1.6
—
—
—
0
0
20
72
2.80
4.29
1.5
1.6
—
—
—
0
0
66
391
1.72
4.10
2.9
3.7
53.34
73.21
mg/l
0.38
57
319
66
391
1.72
4.10
2.9
3.7
26.63
36.42
mg/l
0.67
56
320
106
708
1.53
4.07
1.7
1.6
—
—
—
0
0
149
1067
1.44
4.05
6.2
7.6
9.45
8.88
mmol/l
0.43
142
1020
22
87
2.55
3.97
1.4
1.5
—
—
—
0
0
18
64
2.83
3.96
1.0
1.2
12.69
10.41
u/l
0.42
13
56
107
721
1.52
3.95
6.3
7.4
25.08
25.03
mmol/l
0.05
107
716
75
465
1.64
3.95
2.3
2.0
1.63
1.99
ug/l
0.16
68
417
45
241
1.89
3.90
1.4
1.4
—
—
—
0
0
21
84
2.52
3.72
1.1
1.1
18.10
21.33
u/l
0.15
21
69
1608
15711
1.66
3.68
29.1
19.1
275.56
257.26
e9/l
21.85
1574
15348
65
399
1.65
3.58
1.4
1.2
11.30
11.28
u/ml
—
6
70
1608
15718
1.65
3.58
29.2
19.1
7.54
6.55
e9/l
63.21
1570
15307
1608
15721
1.65
3.53
29.1
19.1
4.44
4.48
e12/l
2.96
1570
15310
1606
15699
1.63
3.50
29.1
19.2
40.21
40.10
%
0.34
1501
14787
1608
15725
1.64
3.48
29.4
19.2
134.14
134.92
g/l
1.48
1591
15516
15
52
2.90
3.46
1.2
1.2
—
—
—
0
0
30
580
0.51
3.45
1.4
1.7
3.30
4.25
mg/l
0.34
24
421
123
877
1.43
3.45
3.0
2.8
4.63
4.54
kpa
0.19
116
844
64
396
1.64
3.43
2.0
1.9
5.02
5.00
iu/l
0.00
22
137
146
1075
1.39
3.42
1.2
1.2
120.37
160.75
iu/ml
0.59
48
426
44
248
1.80
3.30
1.9
1.7
—
—
—
0
0
33
169
1.97
3.30
2.4
2.3
45.80
28.14
mg/l
0.55
15
46
169
1284
1.35
3.27
3.1
2.3
33.99
40.26
u/l
0.50
138
1107
22
97
2.28
3.20
1.6
1.7
—
—
—
0
0
14
49
2.87
3.19
2.1
3.9
319.67
129.04
umol/l
—
9
28
14
49
2.87
3.19
1.1
1.3
—
—
—
0
0
109
774
1.44
3.15
3.4
3.2
5.30
5.14
kpa
1.09
103
747
34
181
1.90
3.06
1.4
1.5
—
—
—
0
0
50
301
1.68
3.01
4.3
2.6
25.22
24.72
mmol/l
0.35
50
296
669
6021
1.19
2.89
2.9
2.7
129.64
112.93
ug/l
0.34
613
5594
103
738
1.42
2.86
3.3
3.2
1.93
1.75
mmol/l
0.18
84
562
77
522
1.50
2.84
1.3
1.9
1.84
1.61
g/l
1.17
66
457
21
97
2.18
2.77
1.3
1.2
—
—
—
0
0
37
211
1.77
2.72
1.2
1.4
28.32
30.57
u/l
0.17
29
176
144
1102
1.34
2.69
6.3
7.1
1.30
1.33
mmol/l
0.13
139
1075
34
190
1.81
2.67
1.4
1.5
—
—
—
0
0
21
99
2.14
2.65
1.3
1.2
—
—
—
0
0
37
213
1.75
2.64
1.4
1.5
—
—
—
0
0
41
244
1.70
2.61
1.4
1.4
—
—
—
0
0
68
458
1.51
2.61
1.5
1.7
—
—
—
0
0
21
100
2.11
2.59
1.1
1.2
1.98
1.94
mmol/l
0.09
21
95
43
260
1.67
2.59
4.4
2.4
8.45
8.11
kpa
0.68
43
255
296
2493
1.23
2.57
3.0
3.0
2.48
2.45
mmol/l
4.31
255
2207
26
136
1.93
2.51
1.5
1.7
—
—
—
0
0
50
319
1.58
2.45
1.5
1.6
—
—
—
0
0
44
272
1.63
2.45
3.5
2.1
130.43
130.70
g/l
0.03
35
197
15
64
2.36
2.39
2.2
2.5
44753.33
39053.88
ug/l
0.38
15
64
12
46
2.62
2.36
1.2
1.2
—
—
—
0
0
44
277
1.60
2.30
1.3
2.0
0.84
0.87
nmol/l
0.08
39
234
31
178
1.76
2.27
1.6
1.6
—
—
—
0
0
99
737
1.36
2.25
1.6
1.4
—
—
—
0
0
7
18
3.90
2.25
1.0
1.2
—
—
—
0
0
131
1018
1.31
2.24
2.2
2.4
23.32
23.74
au/ml
—
6
74
28
159
1.77
2.14
1.0
1.1
—
—
—
0
0
12
49
2.46
2.10
2.7
4.1
—
—
—
0
0
56
382
1.48
2.08
2.2
2.1
12.30
11.68
mg/l
0.18
48
353
37
231
1.62
2.03
1.5
1.7
—
—
—
0
0
7
21
3.34
1.96
2.6
1.4
138.71
90.68
ng/l
—
7
21
20
107
1.88
1.86
1.3
1.1
—
39.00
—
0
6
188
1565
1.23
1.85
2.9
2.7
6.84
7.62
umol/l
0.30
154
1359
15
290
0.51
1.85
1.2
1.4
—
—
—
0
0
73
537
1.38
1.84
2.7
2.5
0.62
0.65
%
0.38
73
532
20
108
1.86
1.82
1.3
1.1
—
34.22
—
0
9
49
336
1.47
1.81
3.1
3.3
1.60
1.51
mg/l
0.27
44
316
19
101
1.89
1.81
1.8
1.5
72.74
77.49
umol/l
0.37
19
101
15
73
2.06
1.80
1.1
1.5
16.16
23.99
umol/l
0.73
15
68
44
298
1.49
1.73
1.1
1.4
—
—
—
0
0
955
9043
1.13
1.73
3.2
2.9
—
—
—
0
0
8
30
2.67
1.72
1.4
1.6
—
—
—
0
0
14
68
2.07
1.70
1.1
1.3
—
—
—
0
0
16
82
1.96
1.69
1.3
1.5
—
—
—
0
0
30
188
1.61
1.66
1.1
1.1
—
—
—
0
0
27
428
0.62
1.66
1.5
1.5
—
—
—
0
0
69
513
1.36
1.65
3.5
3.4
47.60
48.95
%
0.16
69
504
19
105
1.82
1.63
1.5
2.3
800.00
610.11
ml
—
10
75
19
105
1.82
1.63
3.4
2.3
—
—
—
0
0
10
42
2.39
1.61
1.3
1.5
64.35
76.33
nmol/24h
—
10
42
54
387
1.41
1.61
1.7
2.1
118.52
2814.81
u/l
1.92
24
158
13
63
2.07
1.60
1.5
2.0
—
—
—
0
0
14
70
2.01
1.59
1.1
1.3
—
—
—
0
0
37
248
1.50
1.56
1.3
1.3
—
—
—
0
0
37
248
1.50
1.56
1.3
1.3
—
—
—
0
0
45
315
1.44
1.53
1.5
1.6
—
—
—
0
0
54
391
1.39
1.53
1.7
2.5
4.14
3.59
g/l
1.51
49
372
18
100
1.81
1.53
1.3
1.3
4760.00
150476.04
e6/l
—
7
53
78
599
1.32
1.53
1.9
2.0
38.88
39.29
u/l
0.06
66
533
152
1267
1.22
1.52
1.7
2.0
—
—
—
0
0
693
6476
1.12
1.50
2.7
2.5
—
—
—
0
0
13
243
0.53
1.49
1.5
1.4
—
—
—
0
0
13
243
0.53
1.49
1.5
1.4
—
—
—
0
0
13
243
0.53
1.49
1.5
1.4
—
—
—
0
0
13
242
0.53
1.47
1.5
1.4
—
—
—
0
0
17
94
1.82
1.47
1.3
1.1
—
—
—
0
0
10
45
2.23
1.46
1.3
2.0
38.06
53.33
ug/l
—
10
45
9
38
2.38
1.45
1.2
2.3
—
—
—
0
0
21
125
1.69
1.44
1.5
1.6
—
—
—
0
0
21
125
1.69
1.44
1.5
1.6
—
—
—
0
0
21
125
1.69
1.44
1.5
1.6
—
—
—
0
0
198
1704
1.18
1.42
4.4
4.4
31.26
32.53
%
0.99
155
1172
72
555
1.31
1.39
2.7
2.5
1.83
1.22
%
2.65
72
550
7
29
2.42
1.39
1.0
1.3
—
—
—
0
0
7
29
2.42
1.39
1.0
1.2
—
—
—
0
0
41
289
1.43
1.37
1.9
2.1
4.95
5.29
mmol/24h
0.30
36
250
136
1136
1.21
1.35
1.6
1.8
—
—
—
0
0
15
259
0.58
1.33
1.4
1.5
—
—
—
0
0
11
54
2.04
1.33
1.5
1.1
102.27
110.13
%
0.28
11
46
9
44
2.05
1.27
1.8
1.8
—
—
—
0
0
20
123
1.63
1.24
3.0
3.4
—
—
—
0
0
13
70
1.86
1.24
1.5
1.9
—
—
—
0
0
13
70
1.86
1.24
1.5
1.9
—
—
—
0
0
140
1644
0.84
1.22
3.0
2.9
0.62
0.74
ug/l
1.73
93
1046
92
747
1.25
1.21
1.0
1.0
—
—
—
0
0
24
156
1.55
1.20
2.2
2.4
—
—
—
0
0
37
266
1.40
1.15
2.4
3.1
31.32
35.70
umol/l
0.68
37
244
18
112
1.61
1.09
1.1
1.1
—
—
—
0
0
26
178
1.47
1.05
1.2
1.5
—
—
—
0
0
5
22
2.28
1.03
2.4
1.2
—
—
—
0
0
11
60
1.84
1.03
1.1
1.2
3.82
4.73
umol/l
0.43
11
55
18
114
1.59
1.02
1.3
1.3
5395.13
3118.27
e6/l
—
8
75
18
114
1.59
1.02
1.2
1.4
—
—
—
0
0
9
48
1.88
1.00
1.9
1.7
—
—
—
0
0
48
617
0.77
1.00
1.4
1.5
—
—
—
0
0
35
258
1.36
0.97
2.7
2.6
1.72
1.53
mmol/l
0.62
35
248
10
54
1.86
0.96
1.1
1.3
—
—
—
0
0
129
1112
1.17
0.96
3.1
2.5
65.26
68.34
ml/min/173m2
0.41
52
439
44
339
1.31
0.92
1.2
1.3
—
—
—
0
0
31
227
1.37
0.91
1.4
1.6
—
—
—
0
0
31
227
1.37
0.91
1.4
1.6
—
—
—
0
0
11
63
1.75
0.90
2.5
2.1
11.00
264.33
ug/min
—
5
9
24
168
1.43
0.90
1.1
1.8
—
1552.00
—
0
5
216
1944
1.13
0.90
1.9
2.2
30.64
29.41
s
1.71
209
1887
23
160
1.44
0.89
1.0
1.1
—
—
—
0
0
12
71
1.70
0.89
1.0
1.0
—
—
—
0
0
52
415
1.26
0.85
1.2
1.2
—
—
—
0
0
19
129
1.48
0.83
1.1
1.2
—
—
—
0
0
186
1668
1.13
0.83
6.6
6.1
—
—
—
0
0
29
214
1.36
0.82
1.1
1.1
—
—
—
0
0
15
97
1.55
0.81
1.6
2.1
11.73
14.45
%
0.54
15
92
14
89
1.58
0.81
1.0
1.2
—
—
—
0
0
23
317
0.72
0.80
3.0
3.8
15.70
29.87
u/ml
2.39
23
309
9
147
0.61
0.79
1.8
1.5
—
—
—
0
0
7
122
0.57
0.78
1.3
1.5
0.98
0.97
g/l
—
7
122
32
243
1.32
0.77
2.8
2.7
9.53
7.28
mmol/l
0.81
32
234
32
415
0.77
0.76
1.4
1.5
112.25
204.43
pmol/l
1.01
32
409
32
244
1.32
0.75
1.2
1.2
1.73
4.73
u/ml
1.18
11
73
110
961
1.15
0.74
3.1
3.0
162.32
166.57
ng/l
0.05
103
876
23
167
1.38
0.73
1.3
1.3
—
—
—
0
0
9
55
1.64
0.73
1.2
1.3
—
—
—
0
0
9
55
1.64
0.73
1.2
1.3
—
—
—
0
0
5
25
2.00
0.72
3.6
1.8
1.15
1.21
mmol/l
—
5
25
6
106
0.56
0.72
1.2
1.5
13.40
11.89
umol/l
—
6
100
9
56
1.61
0.72
2.2
2.3
—
—
—
0
0
51
417
1.23
0.71
1.2
1.1
—
—
—
0
0
14
204
0.68
0.68
1.7
1.5
—
—
—
0
0
7
43
1.63
0.67
1.0
2.2
—
—
—
0
0
351
3294
1.08
0.66
2.4
2.2
—
—
—
0
0
7
44
1.59
0.65
1.0
1.2
—
—
—
0
0
14
95
1.48
0.64
1.9
2.0
—
—
—
0
0
60
506
1.19
0.63
2.6
3.5
941.70
2793.46
u/ml
0.43
48
437
6
102
0.59
0.62
1.3
1.4
1.76
1.59
g/l
—
6
102
23
173
1.33
0.62
1.2
1.5
—
—
—
0
0
29
226
1.29
0.61
1.0
1.1
—
—
—
0
0
39
478
0.81
0.61
2.7
1.8
—
—
—
0
0
18
130
1.39
0.61
3.2
2.0
4.29
6.97
umol/l
0.72
13
88
259
2779
0.92
0.60
1.5
1.4
—
—
—
0
0
19
139
1.37
0.60
1.5
1.7
—
—
—
0
0
23
174
1.33
0.60
1.2
1.5
—
—
—
0
0
23
174
1.33
0.60
1.2
1.5
—
—
—
0
0
23
174
1.33
0.60
1.2
1.5
—
—
—
0
0
30
236
1.28
0.60
1.2
1.2
2.92
6.09
u/ml
1.20
12
92
0
22
0.00
0.59
0.0
5.5
—
67.59
—
0
17
10
64
1.57
0.58
2.4
3.3
—
—
—
0
0
8
53
1.51
0.58
1.0
1.2
—
—
—
0
0
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
20
151
1.33
0.54
1.5
1.6
—
—
—
0
0
6
40
1.50
0.51
1.0
1.2
—
—
—
0
0
9
65
1.39
0.50
2.6
2.8
856.22
972.71
u/ml
—
9
65
46
390
1.18
0.49
1.3
1.3
—
—
—
0
0
63
549
1.15
0.49
1.2
1.8
—
—
—
0
0
49
419
1.17
0.48
1.2
1.1
—
—
—
0
0
17
128
1.33
0.47
1.5
1.6
—
—
—
0
0
49
420
1.17
0.47
2.5
1.6
262.48
322.98
mu/l
1.20
44
379
19
244
0.78
0.47
1.2
1.2
378.70
281.68
u/ml
—
10
147
36
300
1.20
0.47
1.6
1.3
10.59
11.76
u/l
0.22
27
234
29
239
1.22
0.42
1.1
1.1
—
—
—
0
0
5
32
1.56
0.42
1.0
1.2
—
—
—
0
0
212
2252
0.93
0.41
3.9
4.1
20.68
21.01
%
0.11
90
1023
5
33
1.52
0.41
1.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
27
222
1.22
0.41
2.1
1.6
—
—
—
0
0
22
177
1.25
0.40
1.2
1.5
—
—
—
0
0
5
35
1.43
0.39
1.2
1.0
—
—
—
0
0
19
151
1.26
0.38
3.7
4.8
18.78
60.54
u/ml
—
6
49
11
80
1.38
0.38
1.0
1.1
—
—
—
0
0
9
66
1.37
0.38
1.9
1.3
198.56
403.13
u/l
—
9
60
21
258
0.81
0.38
1.2
1.2
—
—
—
0
0
9
67
1.35
0.38
1.0
1.1
—
—
—
0
0
77
701
1.10
0.34
1.4
1.8
—
—
—
0
0
18
145
1.24
0.33
1.4
1.4
270.91
280.46
mosm/kgh2o
0.64
11
114
15
118
1.27
0.33
1.1
1.2
0.24
0.75
u/ml
—
9
58
11
144
0.76
0.33
1.0
1.1
—
—
—
0
0
6
87
0.69
0.33
1.5
1.7
—
—
—
0
0
19
230
0.82
0.31
1.1
1.1
—
10.41
—
0
14
7
52
1.35
0.31
1.1
2.3
—
46791.30
—
0
10
30
259
1.16
0.30
1.6
1.7
48.90
40.12
nmol/l
0.58
30
250
7
57
1.23
0.29
1.0
1.1
1656.43
1772.18
miu/ml
—
7
57
8
62
1.29
0.28
1.3
1.1
—
—
—
0
0
42
375
1.12
0.27
1.0
1.1
—
—
—
0
0
24
278
0.86
0.26
6.1
3.5
17.81
23.07
mg/l
0.51
11
172
108
1019
1.06
0.23
2.4
2.3
3.41
6.89
ug/l
6.80
89
908
12
97
1.24
0.23
1.1
1.1
1.06
1.04
ratio
—
6
39
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
41
371
1.11
0.22
2.2
3.6
0.37
0.39
u/ml
0.14
30
206
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
7
95
0.74
0.22
1.1
1.3
—
—
—
0
0
14
116
1.21
0.22
1.0
1.0
—
—
—
0
0
5
41
1.22
0.22
1.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
5.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
10
80
1.25
0.20
1.0
1.1
—
—
—
0
0
16
136
1.18
0.20
1.5
1.2
—
—
—
0
0
13
108
1.21
0.20
1.2
1.1
—
—
—
0
0
13
108
1.21
0.20
1.2
1.1
—
—
—
0
0
6
53
1.13
0.18
2.8
1.6
—
—
—
0
0
6
53
1.13
0.18
3.0
2.2
165.17
148.87
nmol/l
—
6
47
13
109
1.19
0.18
1.2
1.1
—
—
—
0
0
13
109
1.19
0.18
1.2
1.1
—
—
—
0
0
13
109
1.19
0.18
1.2
1.1
—
—
—
0
0
29
321
0.90
0.18
1.3
1.4
643.00
1731.48
e6/l
0.50
23
258
29
321
0.90
0.18
1.2
1.4
3.36
14.29
e6/l
1.88
22
246
11
91
1.21
0.17
1.5
1.7
—
—
—
0
0
13
110
1.18
0.17
1.5
2.0
1.00
2.30
u/field
—
5
53
12
101
1.19
0.16
1.0
1.1
—
—
—
0
0
18
158
1.14
0.16
1.4
1.4
—
—
—
0
0
18
158
1.14
0.16
1.4
1.4
—
—
—
0
0
47
438
1.08
0.16
1.6
1.3
153.41
225.81
miu/ml
0.83
19
212
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
83
1.21
0.15
1.0
1.1
—
—
—
0
0
16
180
0.89
0.13
1.5
1.4
—
—
—
0
0
24
262
0.91
0.12
1.1
1.1
0.87
2.34
u/ml
1.32
15
141
64
671
0.95
0.12
2.3
2.2
10.65
12.20
nmol/l
0.76
57
609
30
278
1.08
0.12
1.2
1.6
—
—
—
0
0
20
220
0.91
0.12
1.6
1.5
0.20
0.32
nmol/l
1.27
12
159
13
147
0.88
0.11
1.0
1.1
0.03
0.41
u/ml
—
7
45
5
47
1.06
0.09
1.2
2.2
16.80
27.45
%
—
5
42
5
62
0.81
0.08
1.0
1.3
81.16
153.33
pmol/l
—
5
62
7
68
1.03
0.07
1.0
1.1
—
—
—
0
0
27
283
0.95
0.05
1.6
1.6
—
—
—
0
0
16
171
0.94
0.05
1.7
1.6
—
—
—
0
0
76
774
0.98
0.03
1.5
1.4
—
—
—
0
0
19
181
1.05
0.03
2.1
1.9
153.26
203.08
pmol/l
1.67
19
171
23
239
0.96
0.02
1.5
1.4
68.83
131.95
u/ml
—
6
47
144
1428
1.01
0.02
2.6
4.3
57.12
21.34
ug/l
0.44
114
1158
279
2780
1.00
0.01
4.3
4.7
1.86
2.58
ug/l
1.47
241
2503
10
106
0.94
0.01
1.0
1.1
—
—
—
0
0
13
124
1.05
0.00
1.2
1.3
—
—
—
0
0
12
125
0.96
0.00
2.3
2.4
—
—
—
0
0
21
209
1.00
0.00
1.0
1.1
1.74
2.07
u/ml
0.09
14
103
23
229
1.00
0.00
1.1
1.1
6.50
5.33
u/ml
0.14
14
111
63
631
1.00
0.00
1.5
1.4
—
—
—
0
0
72
719
1.00
0.00
1.5
1.3
34.52
35.17
iu/l
0.06
58
610
0
7
0.00
0.00
0.0
1.0
—
8.81
—
0
7
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
37.06
—
0
7
0
7
0.00
0.00
0.0
1.0
—
22.16
—
0
7
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
5.0
—
375.57
—
0
7
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
60
1.00
-0.00
1.8
1.1
—
—
—
0
0
5
58
0.86
-0.00
1.4
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
8
83
0.96
-0.00
1.4
1.4
—
—
—
0
0
9
94
0.96
-0.00
1.1
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
2.40
—
0
5
0
6
0.00
-0.00
0.0
5.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
59
0.85
-0.00
1.4
2.0
—
—
—
0
0
5
58
0.86
-0.00
1.4
2.0
—
—
—
0
0
7
75
0.93
-0.00
4.3
6.8
—
66.84
u/ml
—
0
19
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_PSORI_PUSTUPALM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_PSORI_PUSTUPALM | 1.24 [1.1, 1.4] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.688 |
During the follow-up period (1.1.1998 — 31.12.2019), 556 out of 5683 females with L12_PSORI_PUSTUPALM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_PSORI_PUSTUPALM | 1.432 [1.25, 1.64] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.009 |
During the follow-up period (1.1.1998 — 31.12.2019), 387 out of 2303 males with L12_PSORI_PUSTUPALM died.
Mortality risk
Mortality risk for people of age
years, who have L12_PSORI_PUSTUPALM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.121% | 0.28% |
| 5 | 0.713% | 1.631% |
| 10 | 1.761% | 4.463% |
| 15 | 3.768% | 8.079% |
| 20 | 7.043% | 14.014% |
Relationships between endpoints
↥Index endpoint: L12_PSORI_PUSTUPALM – Pustulosis palmaris et plantaris
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data